Illumina (ILMN) Stock
Fundamentals
Source: third-party data provider, as of October 14, 2026
Compare with ILMN
Recent news

Where Will Illumina Stock Be in 5 Years If Its AI Bet Pays Off?
Where Will Illumina Stock Be in 5 Years If Its AI Bet Pays Off?
ILMN

REGN or ILMN: Which Is the Better Value Stock Right Now?
REGN or ILMN: Which Is the Better Value Stock Right Now?
ILMN

Is the Options Market Predicting a Spike in Illumina Stock?
Is the Options Market Predicting a Spike in Illumina Stock?
ILMN

Illumina Stock Surges 94.9% YTD: What's Behind the Rally?
Illumina Stock Surges 94.9% YTD: What's Behind the Rally?
ILMN
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 58.63
- MACD 12/26/9
- 13.81
- EMA 9 of MACD
- 15.22
- MACD histogram
- -1.41
- SMA 50
- $229.81
- Price above SMA 50
- EMA 50
- $236.57
- Price above EMA 50
- SMA 200
- $167.65
- Price above SMA 200
- EMA 200
- $177.12
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 13, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 12 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $1.23 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Where Will Illumina Stock Be in 5 Years If Its AI Bet Pays Off?
Where Will Illumina Stock Be in 5 Years If Its AI Bet Pays Off?
ILMN

REGN or ILMN: Which Is the Better Value Stock Right Now?
REGN or ILMN: Which Is the Better Value Stock Right Now?
ILMN

Is the Options Market Predicting a Spike in Illumina Stock?
Is the Options Market Predicting a Spike in Illumina Stock?
ILMN

Illumina Stock Surges 94.9% YTD: What's Behind the Rally?
Illumina Stock Surges 94.9% YTD: What's Behind the Rally?
ILMN

3 Analysts, 3 Trades to Make Today
3 Analysts, 3 Trades to Make Today
ILMN

Illumina (ILMN) is a Top-Ranked Momentum Stock: Should You Buy?
Illumina (ILMN) is a Top-Ranked Momentum Stock: Should You Buy?
ILMN

3 Stocks Soon Joining the S&P 500
3 Stocks Soon Joining the S&P 500
ILMN

3 Promising Genomics Stocks in the Spotlight in 2026
3 Promising Genomics Stocks in the Spotlight in 2026
ILMN

Bloom Energy’s S&P 500 Entry Could Bring A New Wave Of Buyers, Says Clear Street — Projects 20% Upside In BE Stock
Bloom Energy’s S&P 500 Entry Could Bring A New Wave Of Buyers, Says Clear Street — Projects 20% Upside In BE Stock
ILMN

Illumina (ILMN) Upgraded to Buy: What Does It Mean for the Stock?
Illumina (ILMN) Upgraded to Buy: What Does It Mean for the Stock?
ILMN
News tone: automated (AI) classification of the article's content, not a price prediction.
About Illumina
As a startup, Illumina aspired to transform human health. Our initial products enabled researchers to explore DNA at an entirely new scale, helping them create the first map of gene variations associated with health, disease, and drug response. Every breakthrough opened up a new world, and showed us how much further there is to go.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Jacob Thaysen Ph.D. | CEO, President & Director | 1975 |
| Mr. Ankur Dhingra CPA | Chief Financial Officer | 1976 |
| Mr. Kevin Carl Pegels | Chief of Global Operations | 1968 |
| Dr. Steven Barnard Ph.D. | Chief Technology Officer | 1961 |
| Mr. Scott Ericksen | VP & Chief Accounting Officer | 1973 |
| Mr. Mark Field | Chief Information Officer | 1971 |
| Mr. Conor Noel McNamara C.F.A. | VP of Investor Relations | — |
| Ms. Julie Ann Coletti J.D. | Chief Legal Officer | 1968 |
| Mr. Jakob Wedel | Chief Strategy & Corporate Development Officer | 1972 |
| Ms. Patricia Leckman | Senior VP & Chief People Officer | 1964 |
Fundamentals
Valuation
Earnings Per Share
Income Statement
Dividend
Source: third-party data provider, as of October 14, 2026
Technical indicators
- RSI 14
- 58.63
- MACD 12/26/9
- 13.81
- EMA 9 of MACD
- 15.22
- MACD histogram
- -1.41
- SMA 50
- $229.81
- Price above SMA 50
- EMA 50
- $236.57
- Price above EMA 50
- SMA 200
- $167.65
- Price above SMA 200
- EMA 200
- $177.12
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 13, 2026. Technical data, not a recommendation.
Analyst views
12 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $113.00
- Average
- $246.50
- High
- $310.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +1.3 | -12.3 | +6.4 | |||||||||
| 2022 | -8.4 | -8.4 | +5.8 | -18.5 | -20.4 | -21.6 | +13.4 | -6.5 | -4.9 | +22.2 | -0.5 | -8.4 |
| 2023 | +6.6 | -8.0 | +17.1 | -10.6 | -2.8 | -5.8 | +2.1 | -12.7 | -18.5 | -19.8 | -4.4 | +26.8 |
| 2024 | +3.9 | -4.1 | -2.3 | -7.3 | -16.4 | +1.0 | +16.2 | +7.4 | +0.1 | +11.8 | -3.7 | -7.9 |
| 2025 | +1.4 | -32.3 | -5.8 | -1.0 | +7.5 | +17.7 | +4.6 | +5.6 | -2.9 | +20.8 | +9.6 | +1.9 |
| 2026 | +7.8 | -4.7 | -7.2 | +0.1 | +20.0 | +7.0 | +11.5 | +7.8 | +32.1 | +2.1 |



